DC vaccinations in mouse colon cancer model. CT-26 cells (5 × 10 5... | Download Scientific Diagram
Frontiers | Astragaloside III Enhances Anti-Tumor Response of NK Cells by Elevating NKG2D and IFN-γ
CT26 Xenograft Model | Xenograft Services
CTLA-4 immunotherapy exposes differences in immune response along with different tumor progression in colorectal cancer | Aging
In Vivo Syngeneic Subcutaneous CT26 Colon Tumor Model Shuttle Session - by Explicyte Immuno-Oncology
Humanized CT26-hPD-L1 Syngeneic Cell Line | Immuno-Oncology | genOway
Inhibition of colorectal cancer liver metastasis in BALB/c mice following intratumoral injection of oncolytic herpes simplex virus type 2 for the induction of specific antitumor immunity
JCI - Minimal PD-1 expression in mouse and human NK cells under diverse conditions
CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies
Immunogenic chemotherapy in two mouse colon cancer models - Taniura - 2020 - Cancer Science - Wiley Online Library
In Vivo Antitumor Effect against Murine Cells of CT26 Colon Cancer and EL4 Lymphoma by Autologous Whole Tumor Dead Cells
a Growth of Sa1N, CT26, ASB-XIV, or MC38 syngeneic tumors was measured... | Download Scientific Diagram
Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy
CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies
IJMS | Free Full-Text | Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment | HTML
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors | BMC Genomics | Full Text
Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal Cancer | Cancer Genomics & Proteomics
An effective vaccine against colon cancer in mice: Use of recombinant adenovirus interleukin-12 transduced dendritic cells
CT26.WT: Murine Colon Carcinoma - 亚博名字,亚博全站官网,亚博国际游戏官网
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response | BMC Cancer | Full Text
Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities
Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression - ScienceDirect
Immunogenic chemotherapy in two mouse colon cancer models - Taniura - 2020 - Cancer Science - Wiley Online Library
JCI - Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
CT26 Syngeneic Mouse Model - Altogen Labs
PD1 / PDL1 Blockade In Mouse Tumor Syngeneic Models - by Explicyte Immuno-Oncology
